In a prespecified economic analysis of the REHAB-HF trial, we evaluated the cumulative medical resource use and costs during the 6-month follow-up period. A secondary objective was to estimate the cost-effectiveness of the rehabilitation intervention compared with a control condition....
北京时间5月16日晚20点整,美国心脏病学会第70届年会(ACC.21)第二场Late-Breaking Clinical Trial s在Gregory D. Curfman教 授的主持下,先后公布了REHAB-HF、DARE-19、VOYAGER PAD、STRENGTH、PRADA以及ANGPTL3相关的六项重磅研究的最新结果。 速览模式(约2分钟) ACC.21 | LBCT Ⅱ REHAB-HF 个体化的心脏康复...
We explored the interaction between diabetes status and a novel, transitional, tailored, progressive rehabilitation intervention that improved physical function compared with usual care in the Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial.#The effect of the intervention on...
Background The REHAB‐HF (Rehabilitation Therapy in Older Acute Heart Failure Patients) randomized trial demonstrated that a 3‐month transitional, tailored, progressive, multidomain physical rehabilitation intervention improves physical function, frailty, depression, and health‐related quality of life among...
These findings support the feasibility and rationale for a recently launched, National Institutes of Health–funded trial to test the safety and efficacy of this novel multidomain physical rehabilitation intervention toimprove physical function and reduce rehospitalizations in older, frail patients with ...